LKH-Universitätsklinikum Graz

Graz A-8036

5 studies enrolling now · 14 studies all time

What they study most

Acute Myocardial Infarction, Alpha1-Antitrypsin Deficiency, Atrial Fibrillation, Bone Neoplasms, Carcinoma, Pancreatic Ductal, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities, Cryptogenic Ischemic Stroke, Cryptogenic Symptomatic Transient Ischemic Attack, Deep Venous Thrombosis, Heart Failure, Infection, Lung Metastases

Studies at this site

• Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein — Recruiting now
• Neoadjuvant Darovasertib in Primary Uveal Melanoma — Recruiting now
• SELUTION4BTK Trial — Recruiting now
• Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis) — Recruiting now
• Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
• A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE — Stopped early
• Enlighten Study: The EV-ICD Post Approval Registry — Running, not enrolling
• Surveillance AFter Extremity Tumor surgerY — Running, not enrolling
• A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma — Completed
• Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) — Completed
• Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer — Stopped early
• REVEAL AF: Incidence of AF in High Risk Patients — Completed
• Safety and Clinical Performance of the Protecta ICD and CRT-D — Completed
• Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke — Completed